Qatar Investment Authority in Lomond Therapeutics Holdings, Inc.
Completed. First disclosed March 26, 2025, in a Schedule 13G (source).
- Investor
- Qatar Investment Authority (Qatar)
- Target
- Lomond Therapeutics Holdings, Inc. (EDGAR CIK 1900520)
- Target country
- United States
- Sector
- Health and Life Sciences (SIC 2834)
- First disclosed
- March 26, 2025, Schedule 13G
- Amount
- Not stated
- Stake at first disclosure
- 7.76%
- Latest stated stake
- 7.76% (March 26, 2025)
Source Filings and Releases
| Date | Document | Stated stake | Link |
|---|---|---|---|
| March 26, 2025 | Schedule 13G | 7.76% | View |
Cite: Middle East Forum, “Qatar Investment Authority in Lomond Therapeutics Holdings, Inc.,” Gulf Sovereign Holdings, accessed October 13, 2026, https://statemoney.meforum.org/deal/qia-lomond-therapeutics-holdings-inc-1900520/.
Gulf money also reaches U.S. universities and lobbyists: the Influence Tracker holds Section 117 gift and contract disclosures and FARA registrations, and the Campus Watch Map places that funding on specific campuses.